Plain-English translation of NCT06878469 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to care for people with rare brain tumors. Researchers will use artificial intelligence to better predict how surgery will go and help identify the best treatment plan for each patient. You'll also participate in a home-based cognitive rehabilitation program designed to help protect your thinking and memory skills after surgery.
Rare brain tumors are difficult to treat because there are so few patients and cases — which means doctors have limited experience knowing what works best. This trial aims to standardize care across hospitals and use artificial intelligence to help predict outcomes, so every patient with a rare brain tumor gets the best possible treatment and support.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll have your surgery at one of two specialized neurosurgery centers in Italy. Before surgery, during discharge, and at 3 months and 12 months after surgery, you'll complete evaluations of your thinking, mood, and overall function. Starting soon after surgery, you'll use special cognitive rehabilitation software at home (on your own computer) to help your brain recover. The study team will track your progress and help predict how well you're likely to recover based on artificial intelligence analysis.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Italy